ZURICH (Reuters) - Unlisted Covis Pharma B.V. started a late-stage U.S. randomized trial of its asthma drug Alvesco in non-hospitalized patients with symptomatic COVID-19, hoping the inhaled drug ...
Type: Inhaled glucocorticoid with a small particle size (1-2 μm) enabling it to reach areas of chronic inflammation in both the large and small airways. Alvesco is indicated for the long-term ...
U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) filing to study the use of Alvesco in COVID-19 Study will evaluate the Safety and Efficacy of Alvesco ...
ZUG, Switzerland, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and Drug Administration (FDA) has granted a public hearing to discuss Makena, the ...
Dundo — Angolan people should not " relax " in the measures against Covid-19, warned Friday the Secretary of State for Hospital Management, Leonardo Inocêncio. Inocêncio, who was speaking to the press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback